Real-world treatment patterns, healthcare resource utilization (HRU) and costs for relapsed/refractory (R/R) large B-cell lymphoma (LBCL): Chimeric antigen receptor T-cell (CAR T) and monoclonal antibodies (MAB) therapies Meeting Abstract
| Authors: | Feng, C.; Murphy, L.; Engel-Nitz, N.; Nguyen, A.; Patel, A.; DuCharme, M.; Fu, C.; Shah, G. |
| Abstract Title: | Real-world treatment patterns, healthcare resource utilization (HRU) and costs for relapsed/refractory (R/R) large B-cell lymphoma (LBCL): Chimeric antigen receptor T-cell (CAR T) and monoclonal antibodies (MAB) therapies |
| Meeting Title: | ISPOR 2023 |
| Journal Title: | Value in Health |
| Volume: | 26 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2023 May 7-10 |
| Meeting Location: | Boston, MA |
| ISSN: | 1098-3015 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2023-06-01 |
| Start Page: | S395 |
| Language: | English |
| ACCESSION: | WOS:001031473302468 |
| PROVIDER: | wos |
| DOI: | 0.1016/j.jval.2023.03.2728 |
| Notes: | Meeting Abstract: RWD178 -- Source: Wos |
